$APYX
Apyx Medical Corp Stock $apyx

$apyx Overview Financials Valuation SEC Filings Company Website

2019 Q3 Form 10-Q Financial Statement

#000071913519000039 Filed on August 07, 2019

Income Statement

Concept	2019 Q3	2019 Q2	2018 Q4
Revenue	$7.575M	$6.649M	$5.926M
YoY Change	106.29%	80.14%	62.0%
Cost Of Revenue	$2.281M	$1.975M	$2.290M
YoY Change	98.18%	71.14%	138.54%
Gross Profit	$5.294M	$4.674M	$3.556M
YoY Change	110.0%	84.23%	31.9%
Gross Profit Margin	69.89%	70.3%	60.01%
Selling, General & Admin	$3.836M	$3.037M	$7.980M
YoY Change	102.11%	37.23%	97.04%
% of Gross Profit	72.46%	64.98%	224.41%
Research & Development	$1.016M	$888.0K	$660.0K
YoY Change	65.74%	16.38%	94.12%
% of Gross Profit	19.19%	19.0%	18.56%
Depreciation & Amortization	$190.0K	$130.0K	$240.0K
YoY Change	227.59%	-24.42%	41.18%
% of Gross Profit	3.59%	2.78%	6.75%
Operating Expenses	$10.05M	$9.096M	$8.640M
YoY Change	89.3%	66.29%	95.48%
Operating Profit	-$4.756M	-$4.422M	-$5.084M
YoY Change	70.59%	50.77%	194.9%
Interest Expense	$0.00	$0.00	$480.0K
YoY Change	-100.0%	-100.0%	433.33%
% of Operating Profit
Other Income/Expense, Net	$557.0K	$203.0K	-$790.0K
YoY Change	-173.0%	2437.5%
Pretax Income	-$4.199M	-$4.219M	-$6.140M
YoY Change	18.25%	44.24%	95.54%
Income Tax	$171.0K	$76.00K	-$1.520M
% Of Pretax Income
Net Earnings	-$4.370M	-$4.338M	-$5.250M
YoY Change	-106.38%	47.65%	540.24%
Net Earnings / Revenue	-57.69%	-65.24%	-88.59%
Basic Earnings Per Share	-$0.13	-$0.13	-$100.00
Diluted Earnings Per Share	-$0.13	-$0.13	-$155.8K
COMMON SHARES
Basic Shares Outstanding	33.92M shares	34.04M shares	33.20M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q3	2019 Q2	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$62.30M	$67.40M	$78.30M
YoY Change	-35.17%	753.16%	690.91%
Cash & Equivalents	$62.27M	$67.36M	$16.60M
Short-Term Investments	$0.00	$0.00	$61.70M
Other Short-Term Assets	$1.700M	$2.000M	$3.300M
YoY Change	183.33%	53.85%	175.0%
Inventory	$7.237M	$6.392M	$3.146M
Prepaid Expenses
Receivables	$7.662M	$5.292M	$3.721M
Other Receivables	$0.00	$0.00	$1.359M
Total Short-Term Assets	$78.91M	$81.96M	$89.84M
YoY Change	-26.22%	268.71%	298.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.645M	$6.300M	$5.788M
YoY Change	13.75%	-0.22%	-4.06%
Goodwill		$185.0K	$185.0K
YoY Change		0.0%	0.0%
Intangibles		$185.0K	$191.0K
YoY Change		-87.75%	-87.35%
Long-Term Investments
YoY Change
Other Assets	$387.0K	$445.0K	$305.0K
YoY Change	0.52%	564.18%	355.22%
Total Long-Term Assets	$8.038M	$6.926M	$6.093M
YoY Change	29.08%	-17.8%	-27.82%
TOTAL ASSETS
Total Short-Term Assets	$78.91M	$81.96M	$89.84M
Total Long-Term Assets	$8.038M	$6.926M	$6.093M
Total Assets	$86.94M	$88.88M	$95.93M
YoY Change	-23.18%	189.96%	209.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.457M	$1.641M	$1.423M
YoY Change	-37.95%	-40.22%	-10.11%
Accrued Expenses	$7.285M	$5.848M	$7.188M
YoY Change	-63.73%	141.65%	734.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$200.0K		$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$9.039M	$7.897M	$8.611M
YoY Change	-59.71%	26.62%	44.17%
LONG-TERM LIABILITIES
Long-Term Debt	$600.0K	$100.0K	$0.00
YoY Change		-95.72%	-100.0%
Other Long-Term Liabilities	$600.0K	$300.0K	$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$1.200M	$400.0K	$0.00
YoY Change		-82.87%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.039M	$7.897M	$8.611M
Total Long-Term Liabilities	$1.200M	$400.0K	$0.00
Total Liabilities	$10.21M	$8.304M	$8.751M
YoY Change	-54.77%	-8.55%	-2.29%
SHAREHOLDERS EQUITY
Retained Earnings	$19.95M	$24.32M	$34.22M
YoY Change	-48.54%	-181.88%	-220.1%
Common Stock	$34.00K	$34.00K	$34.00K
YoY Change	3.03%	3.03%	3.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$76.73M	$79.44M	$87.18M
YoY Change
Total Liabilities & Shareholders Equity	$86.94M	$88.88M	$95.93M
YoY Change	-23.18%	189.96%	209.56%

Cashflow Statement

Concept	2019 Q3	2019 Q2	2018 Q4
OPERATING ACTIVITIES
Net Income	-$4.370M	-$4.338M	-$5.250M
YoY Change	-106.38%	47.65%	540.24%
Depreciation, Depletion And Amortization	$190.0K	$130.0K	$240.0K
YoY Change	227.59%	-24.42%	41.18%
Cash From Operating Activities	-$4.540M	-$5.590M	-$18.04M
YoY Change	291.38%	880.7%	-2537.84%
INVESTING ACTIVITIES
Capital Expenditures	-$560.0K	-$400.0K	-$160.0K
YoY Change	-530.77%	110.53%	-15.79%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$40.88M	-$6.000M
YoY Change	-100.0%
Cash From Investing Activities	-$550.0K	$40.48M	-$6.160M
YoY Change	-101.54%	-21405.26%	3142.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	30.00K	50.00K	140.0K
YoY Change	-101.2%	-183.33%	-333.33%
NET CHANGE
Cash From Operating Activities	-4.540M	-5.590M	-18.04M
Cash From Investing Activities	-550.0K	40.48M	-6.160M
Cash From Financing Activities	30.00K	50.00K	140.0K
Net Change In Cash	-5.060M	34.94M	-24.06M
YoY Change	-115.75%	-4360.98%	-5010.2%
FREE CASH FLOW
Cash From Operating Activities	-$4.540M	-$5.590M	-$18.04M
Capital Expenditures	-$560.0K	-$400.0K	-$160.0K
Free Cash Flow	-$3.980M	-$5.190M	-$17.88M
YoY Change	208.53%	1265.79%	-2022.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	apyx	Income Loss From Discontinued Operations Net Of Tax Attributable To Parent Including Gain From Divestiture IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToParentIncludingGainFromDivestiture	0	USD
	apyx	Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax	4522000	USD
	apyx	Capitalization Of Lease Non Cash CapitalizationOfLeaseNonCash	0	USD
	apyx	Capitalization Of Lease Non Cash CapitalizationOfLeaseNonCash	394000	USD
	apyx	Income Loss From Discontinued Operations Net Of Tax Attributable To Parent Including Gain From Divestiture IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToParentIncludingGainFromDivestiture	4522000	USD
	apyx	Increase Decreasein Accrued Severanceandrelated IncreaseDecreaseinAccruedSeveranceandrelated	-319000	USD
	apyx	Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax Incomelossfromdiscontinuedoperationsanddisposalofdiscontinuedoperationsnetoftax	0	USD
	apyx	Increase Decreasein Accrued Severanceandrelated IncreaseDecreaseinAccruedSeveranceandrelated	0	USD
	apyx	Proceeds From Stock Options Exercised And Warrants Exercised ProceedsFromStockOptionsExercisedAndWarrantsExercised	115000	USD
	apyx	Non Cash Proceeds From Stock Options And Warrants Exercised NonCashProceedsFromStockOptionsAndWarrantsExercised	0	USD
	apyx	Non Cash Proceeds From Stock Options And Warrants Exercised NonCashProceedsFromStockOptionsAndWarrantsExercised	662000	USD
	apyx	Proceeds From Stock Options Exercised And Warrants Exercised ProceedsFromStockOptionsExercisedAndWarrantsExercised	0	USD
	apyx	Provision For Inventory Obsolescence ProvisionForInventoryObsolescence	0	USD
	apyx	Provision For Inventory Obsolescence ProvisionForInventoryObsolescence	36000	USD
CY2018Q4	apyx	Provision For Obsolescence Inventory ProvisionForObsolescenceInventory	439000	USD
CY2019Q2	apyx	Provision For Obsolescence Inventory ProvisionForObsolescenceInventory	402000	USD
CY2018Q2	apyx	Stock Swap To Acquire Options Amount StockSwapToAcquireOptionsAmount	-178000	USD
	apyx	Stock Swap To Acquire Options Amount StockSwapToAcquireOptionsAmount	-178000	USD
CY2019Q2	apyx	Stock Swap To Acquire Options Amount StockSwapToAcquireOptionsAmount	48000	USD
	apyx	Stock Swap To Acquire Options Amount StockSwapToAcquireOptionsAmount	-662000	USD
CY2018Q2	apyx	Warrant Exercised Amount WarrantExercisedAmount	95000	USD
	apyx	Warrant Exercised Amount WarrantExercisedAmount	95000	USD
	apyx	Weighted Average Number Diluted Shares Outstanding Adjustment Discontinued Operations WeightedAverageNumberDilutedSharesOutstandingAdjustmentDiscontinuedOperations	32890000	shares
	apyx	Weighted Average Number Diluted Shares Outstanding Adjustment Discontinued Operations WeightedAverageNumberDilutedSharesOutstandingAdjustmentDiscontinuedOperations	0	shares
	apyx	Weighted Average Numberof Shares Issued Basic Continuing Operations WeightedAverageNumberofSharesIssuedBasicContinuingOperations	32890000	shares
	apyx	Weighted Average Numberof Shares Issued Basic Continuing Operations WeightedAverageNumberofSharesIssuedBasicContinuingOperations	33363000	shares
	apyx	Weighted Average Numberof Shares Issued Basic Discontinued Operations WeightedAverageNumberofSharesIssuedBasicDiscontinuedOperations	32890000	shares
	apyx	Weighted Average Numberof Shares Issued Basic Discontinued Operations WeightedAverageNumberofSharesIssuedBasicDiscontinuedOperations	0	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000719135
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33921476	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	APYX MEDICAL CORP
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1423000	USD
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1641000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5015000	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6218000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5552000	USD
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5848000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52221000	USD
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54051000	USD
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	377000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	749000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.00
CY2018Q4	us-gaap	Assets Current AssetsCurrent	89517000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	817000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	428000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	856000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1715000	USD
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	285000	USD
CY2018Q4	us-gaap	Assets Assets	95610000	USD
CY2019Q2	us-gaap	Assets Assets	88883000	USD
CY2019Q2	us-gaap	Assets Current AssetsCurrent	81957000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	247000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	77897000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	78144000	USD
CY2018Q4	us-gaap	Cash Cash	6337000	USD
CY2019Q2	us-gaap	Cash Cash	3500000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16466000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67360000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10668000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8535000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16466000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67360000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2133000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	50894000	USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34061360	shares
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33847100	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33918785	shares
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33704525	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	34000	USD
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	34000	USD
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1154000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2339000	USD
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2096000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4199000	USD
CY2018Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	73000	USD
CY2019Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	73000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	371000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	316000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare	0.13
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare	0.00
CY2018Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	80.00
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	130.00
CY2019Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.00
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.00
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1046000	USD
CY2018Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	80.00
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	130.00
CY2019Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.00
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-270.00
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-10.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-40.00
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-270.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-10.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-40.00
CY2018Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.032
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.018
CY2019Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.017
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.003
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2018Q4	us-gaap	Goodwill Goodwill	185000	USD
CY2019Q2	us-gaap	Goodwill Goodwill	185000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	2537000	USD
	us-gaap	Gross Profit GrossProfit	4749000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	4472000	USD
	us-gaap	Gross Profit GrossProfit	8192000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5729000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9019000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2925000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5705000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4262000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9067000	USD
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.17
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.27
CY2018Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-90.00
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-170.00
CY2019Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-270.00
CY2018Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-90.00
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-170.00
CY2019Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.13
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-270.00
CY2018Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	2666000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	4522000	USD
CY2019Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-48000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1162000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	218000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-898000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	604000	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-23000	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-321000	USD
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-20000	USD
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1007000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1216000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	72000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	841000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	191000	USD
CY2019Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	185000	USD
CY2018Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	191000	USD
CY2019Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	185000	USD
CY2018Q2	us-gaap	Interest Expense InterestExpense	38000	USD
	us-gaap	Interest Expense InterestExpense	72000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	0	USD
	us-gaap	Interest Expense InterestExpense	0	USD
CY2018Q2	us-gaap	Interest Income Operating InterestIncomeOperating	0	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	0	USD
CY2019Q2	us-gaap	Interest Income Operating InterestIncomeOperating	403000	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	826000	USD
	us-gaap	Interest Paid Net InterestPaidNet	72000	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2018Q4	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	1130000	USD
CY2019Q2	us-gaap	Inventory Finished Goods And Work In Process InventoryFinishedGoodsAndWorkInProcess	1453000	USD
CY2018Q4	us-gaap	Inventory Gross InventoryGross	5651000	USD
CY2019Q2	us-gaap	Inventory Gross InventoryGross	6794000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	5212000	USD
CY2019Q2	us-gaap	Inventory Net InventoryNet	6392000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4521000	USD
CY2019Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	5341000	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	439000	USD
CY2019Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	402000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	403000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	118000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	118000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	111000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	56000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P2Y
CY2018Q4	us-gaap	Liabilities Liabilities	7842000	USD
CY2019Q2	us-gaap	Liabilities Liabilities	8304000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	95610000	USD
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	88883000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7702000	USD
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7897000	USD
CY2018Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	140000	USD
CY2019Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	140000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-120000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	60920000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1681000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-332000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	115000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10141000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-2938000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5729000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-4338000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-9019000	USD
CY2018Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-272000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1207000	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4338000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9019000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1207000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-9019000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	5470000	USD
	us-gaap	Operating Expenses OperatingExpenses	10402000	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	8937000	USD
	us-gaap	Operating Expenses OperatingExpenses	17860000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2933000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5653000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5200000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4465000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9668000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	0	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	53000	USD
CY2019Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	267000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	41000	USD
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	368000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-52000	USD
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	203000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	601000	USD
CY2018Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	USD
CY2019Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-200000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-225000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	18884000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	332000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	922000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1146000	USD
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1987000	USD
CY2018Q3	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	97000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	80726000	USD
CY2018Q2	us-gaap	Professional Fees ProfessionalFees	681000	USD
	us-gaap	Professional Fees ProfessionalFees	1187000	USD
CY2019Q2	us-gaap	Professional Fees ProfessionalFees	1633000	USD
	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6300000	USD
	us-gaap	Professional Fees ProfessionalFees	3424000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5788000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	82000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	164000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	120000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	763000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-157000	USD
CY2019Q2	us-gaap	Purchase Obligation PurchaseObligation	3400000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1277000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	888000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1698000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	35513000	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	26494000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3691000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7088000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6568000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12391000	USD
CY2018Q2	us-gaap	Salaries And Wages SalariesAndWages	1813000	USD
	us-gaap	Salaries And Wages SalariesAndWages	3615000	USD
CY2019Q2	us-gaap	Salaries And Wages SalariesAndWages	3333000	USD
	us-gaap	Salaries And Wages SalariesAndWages	6554000	USD
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2213000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4323000	USD
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3083000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6184000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	749000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1715000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.691
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.691
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	50500	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	6.70
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1277500	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3480701	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4399152	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.10
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.42
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.87
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.73
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	61678000	USD
CY2019Q2	us-gaap	Short Term Investments ShortTermInvestments	0	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	308549	shares
CY2018Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	83000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	83000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	777000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	22032000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	21469000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	21574000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	87768000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	84013000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	80579000	USD
CY2018Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	727000	USD
CY2019Q2	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	408000	USD
	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	1366000	USD
CY2018Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	46000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	20000	USD
CY2019Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1313000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1313000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	53000	USD
	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	32890000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	33363000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	32890000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	33363000	shares
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECENT ACCOUNTING PRONOUNCEMENTS </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other</font><font style="font-family:inherit;font-size:10pt;"> (Topic 350): </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Simplifying the Test for Goodwill Impairment</font><font style="font-family:inherit;font-size:10pt;">. The purpose of this ASU is to reduce the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this ASU, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit’s fair value. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted, however we have chosen not to do so. The amendment will not have a material impact on our financial condition or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU No. 2014-09 (ASC 606), </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;"> became effective for us beginning with the first quarter of 2018, and we adopted the new accounting standard using the modified retrospective transition approach. The modified retrospective transition approach recognized any changes from the beginning of the year of initial application through retained earnings with no restatement of comparative periods. We record revenue under ASC 606 at a single point in time, when control is transferred to the customer, which is consistent with past practice. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure under the new standard. Based on the results of the evaluation, we have determined that the adoption of the new standard presents no material impact on our consolidated financial statements. Application of the transition requirements of the new standard did not have a material impact on opening retained earnings. We have disaggregated revenue by segment and geography in Note 11 Geographic and Segment Information. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (ASU 2016-02), Leases (Topic 842), which became effective for us beginning with the first quarter of 2019. ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability, initially measured at the present value of the lease payments, on the balance sheet for all leases with terms longer than 12 months, as well as the disclosure of key information about leasing arrangements. This new standard requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term, generally on a straight-line basis, and classification of all cash payments within operating activities in the statement of cash flows. The determination of the discount rate used to calculate net present value is based on what we would normally pay to borrow on a collateralized basis over a similar term. Disclosures are required to provide the amount, timing and uncertainty of cash flows arising from leases. In accordance with the standard, we took a modified retrospective transition approach and included the </font><font style="font-family:inherit;font-size:10pt;">$394,000</font><font style="font-family:inherit;font-size:10pt;"> right of use asset and corresponding liabilities in our property plant and equipment, accrued expenses and long term lease liability on the consolidated balance sheet. The lease is also represented in our consolidated statement of cash flows as a non-cash investing activity.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on our consolidated financial statements or disclosures.</font></div></div>

Files In Submission

Name	View Source	Status
0000719135-19-000039-index-headers.html	Edgar Link	pending
0000719135-19-000039-index.html	Edgar Link	pending
0000719135-19-000039.txt	Edgar Link	pending
0000719135-19-000039-xbrl.zip	Edgar Link	pending
a2019q210-q.htm	Edgar Link	pending
a2019q2apyx10-qexhibit311.htm	Edgar Link	pending
a2019q2apyx10-qexhibit312.htm	Edgar Link	pending
a2019q2apyx10-qexhibit321.htm	Edgar Link	pending
a2019q2apyx10-qexhibit322.htm	Edgar Link	pending
apyx-20190630.xml	Edgar Link	completed
apyx-20190630.xsd	Edgar Link	pending
apyx-20190630_cal.xml	Edgar Link	unprocessable
apyx-20190630_def.xml	Edgar Link	unprocessable
apyx-20190630_lab.xml	Edgar Link	unprocessable
apyx-20190630_pre.xml	Edgar Link	unprocessable
apyxmedicallogotagline.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APYX
Apyx Medical Corp Stock $apyx

2019 Q3 Form 10-Q Financial Statement

#000071913519000039 Filed on August 07, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APYX Apyx Medical Corp Stock $apyx

2019 Q3 Form 10-Q Financial Statement

#000071913519000039 Filed on August 07, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APYX
Apyx Medical Corp Stock $apyx